GDI1 and breast cancer: In breast cancer cells, PRKCBP1 is a hypoxia-induced epigenetic reader that interacts with hypoxia-inducible factors (HIFs) 1α and 2α, to amplify HIF-mediated activation of oncogenes, subsequently increasing breast cancer progression and metastasis (Chen et al., 2018).